I was introduced to NVIV on message boards several times before I saw the short-term potential of this company. However, I still don't know why they decided to test every permutation of scaffold/hydrogel/drugs/cells over several years - do they already feel they've cornered the market in the next few years with the scaffold? I am also wondering if anyone here cares to share other 10x companies; I am holding VVUS and KERX now for catalysts within 2 months. Thanks
INO - DNA cancer vaccines using electroporation - universal flu vaccine
CORT - cortisol (stress hormone) uptake inhibitor for cushing's, anti-psychotic weight gain, depression
DVAX - hepatitis B vaccine, more efficacy and fewer doses than current standard
LPTN - Mab's for wet and dry AMD
NVDQ - fluorescence imaging system for surgeons - partnership with ISRG
BGMD - new diagnostic blood test to predict heart failure, partnerships with Humana, Merck and Lab Corp.
CLDX - immunotherapy vaccines for gioblastoma, breast cancer, melanoma